Heide Ford Lab
@heidefordlab.bsky.social
Professor and Chair, Department of Pharmacology
University of Colorado Anschutz Medical Campus
Cancer biologist, metastasis researcher interested in tumor cell plasticity
Colorado and outdoor enthusiast 🏔️🏔️☀️
University of Colorado Anschutz Medical Campus
Cancer biologist, metastasis researcher interested in tumor cell plasticity
Colorado and outdoor enthusiast 🏔️🏔️☀️
Reposted by Heide Ford Lab
We remember and honor Joshua Black, PhD, who passed away on Oct. 25, 2025. Josh was a brilliant scientist, a beloved colleague, and a cherished friend. To honor his legacy and support a research lectureship in his honor, we invite you to contribute in his memory at giving.cu.edu/JBlack.
A gift in memory of Joshua Black, PhD
Join me and make a gift in memory of Joshua Black
giving.cu.edu
November 3, 2025 at 6:37 PM
We remember and honor Joshua Black, PhD, who passed away on Oct. 25, 2025. Josh was a brilliant scientist, a beloved colleague, and a cherished friend. To honor his legacy and support a research lectureship in his honor, we invite you to contribute in his memory at giving.cu.edu/JBlack.
Josh was an amazing colleague, collaborator, and friend. He will be very much missed.
It is with deep sadness that we share our beloved colleague, Josh Black, passed away this past weekend. Josh was a brilliant scientist, generous mentor and cherished friend to many. He will be profoundly missed and fondly remembered by all.
November 2, 2025 at 4:52 AM
Josh was an amazing colleague, collaborator, and friend. He will be very much missed.
Reposted by Heide Ford Lab
A few years ago, Michael Oliphant was a doctoral student working in the lab of @cucancercenter.bsky.social leader @heidefordlab.bsky.social to understand how breast cancer spreads. Now, Oliphant is back at @cuanschutz.bsky.social @cupharmacology.bsky.social, launching his own lab. #cucityofhealth
CU Cancer Center’s Newest Rising Star Focuses on ‘Opposite Ends of the Breast Cancer Spectrum’
Michael Oliphant, PhD, rejoins Heide Ford, PhD, at the CU Department of Pharmacology to study cancer evolution and drug resistance.
news.cuanschutz.edu
September 5, 2025 at 4:24 PM
A few years ago, Michael Oliphant was a doctoral student working in the lab of @cucancercenter.bsky.social leader @heidefordlab.bsky.social to understand how breast cancer spreads. Now, Oliphant is back at @cuanschutz.bsky.social @cupharmacology.bsky.social, launching his own lab. #cucityofhealth
Sharing this new review written by two talented trainees from the Ford lab, Sheera Rosenbaum and Kaiah Fields. @kaiahfields.bsky.social
The ability of #cancer and immune cells to change their phenotype contributes to tumor progression and therapy resistance. @heidefordlab.bsky.social explores the mutual plasticity of cells in the tumor microenvironment and why this matters for the development of therapies 🧪 plos.io/4774Y7a
Masters of adaptation: How cancer and immune cell plasticity mediates tumor progression
The ability of cancer cells and immune cells cell to dynamically change their phenotype contributes to tumor progression and therapy resistance. This Essay explores the mutual plasticity of various ce...
plos.io
August 11, 2025 at 4:11 AM
Sharing this new review written by two talented trainees from the Ford lab, Sheera Rosenbaum and Kaiah Fields. @kaiahfields.bsky.social
So impressed by our new faculty members Justin O’Hare and Debo Sardar for being 2 of only 12 nationally who received the Klingenstein award this year! @debo-astrocyte.bsky.social @justinkohare.bsky.social
Congratulations to Debosmita Sardar, PhD, and Justin O’Hare, PhD, Assistant Professors in the Department of Pharmacology, who have received Klingenstein Fellowships in Neuroscience, one of the nation’s most prestigious awards for early career scientists. Learn More: bit.ly/44y8nJD
July 2, 2025 at 6:28 PM
So impressed by our new faculty members Justin O’Hare and Debo Sardar for being 2 of only 12 nationally who received the Klingenstein award this year! @debo-astrocyte.bsky.social @justinkohare.bsky.social
Excited to share this new paper from my close collaborator’s lab, Rui Zhao. www.jbc.org/article/S002...
Cryo-EM structures reveal the PP2A-B55α and Eya3 interaction that can be disrupted by a peptide inhibitor
We have previously shown that Eya3 recruits PP2A-B55α to dephosphorylate pT58 on Myc,
increasing Myc stability and enhancing primary tumor growth of triple-negative breast
cancer (TNBC). However, the ...
www.jbc.org
May 30, 2025 at 5:43 PM
Excited to share this new paper from my close collaborator’s lab, Rui Zhao. www.jbc.org/article/S002...
Excited to share a new study from the Ford lab: EYA3 regulation of NF-κB and CCL2 suppresses cytotoxic NK cells in the premetastatic niche to promote TNBC metastasis | Science Advances www.science.org/doi/10.1126/...
Congratulations to Sheera Rosenbaum and Connor Hughes, as well as all co-authors!
Congratulations to Sheera Rosenbaum and Connor Hughes, as well as all co-authors!
EYA3 regulation of NF-κB and CCL2 suppresses cytotoxic NK cells in the premetastatic niche to promote TNBC metastasis
EYA3 promotes evasion of cytotoxic NK cells to enable metastasis, highlighting a therapeutic target in metastatic breast cancer.
www.science.org
May 8, 2025 at 6:35 PM
Excited to share a new study from the Ford lab: EYA3 regulation of NF-κB and CCL2 suppresses cytotoxic NK cells in the premetastatic niche to promote TNBC metastasis | Science Advances www.science.org/doi/10.1126/...
Congratulations to Sheera Rosenbaum and Connor Hughes, as well as all co-authors!
Congratulations to Sheera Rosenbaum and Connor Hughes, as well as all co-authors!
So fortunate to work with all these amazing women in our department!
As Women's History Month comes to a close, we celebrate the incredible women on our primary faculty and their invaluable contributions to the pharmacology field. Their dedication to research, mentorship and innovation continues to shape the future of science and medicine. #WomeninSTEM #CUAnschutz
March 30, 2025 at 7:36 PM
So fortunate to work with all these amazing women in our department!
So proud of Ford lab members who have recently defended their theses (Connor Purdy and Art Wolin) and matched into the Duke internal medicine residency (Connor Hughes, MSTP). It’s been a busy couple of months for the lab, but nothing is more special than watching the success of your trainees!
March 24, 2025 at 2:01 AM
So proud of Ford lab members who have recently defended their theses (Connor Purdy and Art Wolin) and matched into the Duke internal medicine residency (Connor Hughes, MSTP). It’s been a busy couple of months for the lab, but nothing is more special than watching the success of your trainees!
Was very excited to host Senator Hickenlooper in my lab this past week, as well as be involved in a panel discussion around the important of federal funding for science!
coloradosun.com/2025/03/19/n...
coloradosun.com/2025/03/19/n...
Funding cuts to CU-Anschutz could erase years of medical research contributed by patients, advocates fear
NIH funding cuts could halt years of progress on medical research contributed by patients at Colorado's CU-Anschutz campus.
coloradosun.com
March 20, 2025 at 11:51 PM
Was very excited to host Senator Hickenlooper in my lab this past week, as well as be involved in a panel discussion around the important of federal funding for science!
coloradosun.com/2025/03/19/n...
coloradosun.com/2025/03/19/n...
Excited to post this op-ed published in the front porch and written by the talented Aimee Bernard in conjunction with the basic science chairs. Opinions are our own. frontporchne.com/opinion-the-...
Opinion: The Critical Need for Science Funding | Front Porch
As chairs of the basic science departments, we are compelled to address a matter of utmost urgency: the critical need for funding in scientific research. In an era where scientific advancements hold t...
frontporchne.com
March 6, 2025 at 2:45 AM
Excited to post this op-ed published in the front porch and written by the talented Aimee Bernard in conjunction with the basic science chairs. Opinions are our own. frontporchne.com/opinion-the-...
Excited to share this new review written by Annika Gustafson, in close collaboration with Kristin Artinger and Adam Durbin @artingerlab.bsky.social
www.frontiersin.org/journals/cel...
www.frontiersin.org/journals/cel...
Frontiers | Myogenesis gone awry: the role of developmental pathways in rhabdomyosarcoma
www.frontiersin.org
March 1, 2025 at 6:55 PM
Excited to share this new review written by Annika Gustafson, in close collaboration with Kristin Artinger and Adam Durbin @artingerlab.bsky.social
www.frontiersin.org/journals/cel...
www.frontiersin.org/journals/cel...
Reposted by Heide Ford Lab
Welcome to the faculty @alebrambati.bsky.social! Read more about Ale’s background and research areas below. 🧬
December 4, 2024 at 5:38 PM
Welcome to the faculty @alebrambati.bsky.social! Read more about Ale’s background and research areas below. 🧬
Interested in doing your postdoc with the Department of Pharmacology at @CUAnschutz? Join us for our Postdoctoral Education & Knowledge Summit with @cuanschutz_dpb and the Department of Biochemistry & Molecular Genetics!
Applications close December 1st. bit.ly/CU-PEAKS
Applications close December 1st. bit.ly/CU-PEAKS
CU PEAKS
bit.ly
November 23, 2024 at 10:42 PM
Interested in doing your postdoc with the Department of Pharmacology at @CUAnschutz? Join us for our Postdoctoral Education & Knowledge Summit with @cuanschutz_dpb and the Department of Biochemistry & Molecular Genetics!
Applications close December 1st. bit.ly/CU-PEAKS
Applications close December 1st. bit.ly/CU-PEAKS
Excited to share my first real post on Bluesky: New preprint from the Ford lab on an eya3/nfkb/ccl2 axis and the pre-metastatic niche in breast cancer. www.biorxiv.org/content/bior...
www.biorxiv.org
November 23, 2024 at 3:46 PM
Excited to share my first real post on Bluesky: New preprint from the Ford lab on an eya3/nfkb/ccl2 axis and the pre-metastatic niche in breast cancer. www.biorxiv.org/content/bior...
Happy to start my migration to bluesky!! Excited to meet you all here and share our science.
November 17, 2024 at 12:18 AM
Happy to start my migration to bluesky!! Excited to meet you all here and share our science.